A clinical trial has begun which will use stem cell transplants to grow a new immune system for people with untreatable Crohn’s disease – a painful and chronic intestinal disease which affects at least 115,000 people in the UK.
The study, led by Queen Mary University of London and Barts Health NHS Trust, is funded with £2m from a Medical Research Council and National Institute for Health Research partnership, and will be recruiting patients from centres in Cambridge, Edinburgh, Liverpool, London, Nottingham, Oxford and Sheffield. The trial is coordinated through the Clinical Trials Unit at the University of Sheffield.
Crohn’s disease is a long-term condition that causes inflammation of the lining of the digestive system, and results in diarrhoea, abdominal pain, extreme tiredness and other symptoms that significantly affect quality of life.
Current treatments include drugs to reduce inflammation but these have varying results, and surgery is often needed to remove the affected part of the bowel. In extreme cases, after multiple operations over the years, patients may require a final operation to divert the bowel from the anus to an opening in the stomach, called a stoma, where stools are collected in a pouch.
‘We might be able to radically alter the course of the disease’
Chief investigator Professor James Lindsay from Queen Mary’s Blizard Institute and a consultant at Barts Health NHS Trust said: “Despite the introduction of new drugs, there are still many patients who don’t respond, or gradually lose response, to all available treatments. Although surgery with the formation of a stoma may be an option that allows patients to return to normal daily activities, it is not suitable in some and others may not want to consider this approach.
“We’re hoping that by completely resetting the patient’s immune system through a stem cell transplant, we might be able to radically alter the course of the disease. While it may not be a cure, it may allow some patients to finally respond to drugs which previously did not work.”
Helen Bartlett, a Crohn’s disease patient who had stem cell therapy at John Radcliffe Hospital, Oxford, said: “Living with Crohn’s is a daily struggle. You go to the toilet so often, you bleed a lot and it’s incredibly tiring. You also always need to be careful about where you go. I’ve had to get off trains before because there’s been no toilet, and I needed to go there and then.
“I’ve been in and out of hospital for the last twenty years, operation after operation, drug after drug, to try to beat this disease. It’s frustrating, it’s depressing and you just feel so low.
“When offered the stem cell transplant, it was a complete no brainer as I didn’t want to go through yet more failed operations. I cannot describe how much better I feel since the treatment. I still have problems and I’m always going to have problems, but I’m not in that constant pain.”
Giving patients a new immune system
The Latest on: Crohn’s disease
via Google News
The Latest on: Crohn’s disease
- B.C. expands biosimilar drug program to include treatments for Crohn's, colitison September 6, 2019 at 9:12 am
In 2018, B.C. spent $125 million to treat chronic conditions such as diabetes, arthritis and Crohn's disease. B.C. shifting to cover cheaper 'biosimilar' drugs, health minister says Will USMCA affect ...
- Crohn's Disease Treatment 2019 Global Market Outlook,Research,Trends and Forecast to 2023on September 6, 2019 at 7:41 am
Sep 06, 2019 (Heraldkeepers) -- WiseGuyReports.Com Publish a New Market Research Report On -"Crohn's Disease Treatment 2019 Global Market Outlook,Research,Trends and Forecast to 2023". Crohn's Disease ...
- Ribbleton with Crohn's disease jumps from the sky for Alzheimer's Societyon September 6, 2019 at 6:23 am
A woman with Crohn’s disease raised more than £1,000 for a charity close to her heart. Suzanne Tustin, 52, performed a tandem skydive to raise £1,250 for The Alzheimer’s Society. Suzanne lives in ...
- Crohn's and Colitis Canada Announces Updated Position Statement on Biosimilar Drugson September 5, 2019 at 9:19 am
5, 2019 /CNW/ - Today, Crohn's and Colitis Canada released their updated Position on biosimilar drugs. Supporting studies, including a report on cross-Canada surveys of patients and caregivers, ...
- What I've Learned From Talking Openly About My Bowel Diseaseon September 1, 2019 at 9:00 pm
The findings came in a letter that I opened alone in my bedroom. It read that the camera’s findings indicated I had Crohn’s disease. What was Crohn’s disease? Well, Crohn’s disease is a form of ...
- 14 Products Everyone With Crohn's Disease Should Keep in Their Bagon August 30, 2019 at 10:06 am
One of the most difficult aspects of Crohn’s disease is the fact that flare-ups can happen literally anywhere — and when those flare-ups happen, you can’t exactly hold them off until you get home.
- Crohn’s Disease Symptoms in Womenon August 30, 2019 at 8:53 am
Many diseases affect men and women equally, but some diseases, such as those that occur in the sex-specific reproductive organs – think prostate cancer or endometriosis – only affect members ...
- Cooking With Crohn's: A Chef With IBD Shares His Best Adviceon August 29, 2019 at 10:14 am
Growing up as a teen with Crohn’s disease, Ryan Van Voorhis, 38, felt his path forward was clear: He was going to become a social worker to help other people the way his own health care team helped ...
- Drug resistance signature discovered in Crohn's diseaseon August 29, 2019 at 8:02 am
The study analyzed biopsy samples of inflamed and uninflamed Crohn's disease lesions on small intestine tissue as soon as it was removed from patients. Researchers used single-cell RNA sequencing ...
via Bing News